A Phase II Randomized, Double-blind, Active Placebo-controlled Parallel Group Trial to Examine the Efficacy and Safety of Psilocybin in Treatment-resistant Major Depression - Central Institute of Mental Health; Mannheim (ClinicalTrials.gov, 2025)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com